These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2066046)

  • 21. Low adherence of General Practitioners to National Cholesterol Education Program guidelines for the management of hyperlipidaemia.
    Fornengo P; Bruno G; De Salvia A; Arcari R; Pisu E; Pagano G
    Diabetes Nutr Metab; 2000 Oct; 13(5):263-8. PubMed ID: 11105968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipid disorders in type 2 diabetes.
    Braun LT
    Nurs Clin North Am; 2001 Jun; 36(2):291-302, vii. PubMed ID: 11382564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood cholesterol disorders: the iceberg base or nondisease?
    de Ferranti SD
    Med Clin North Am; 2012 Jan; 96(1):141-54. PubMed ID: 22391258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood lipids in the Swiss population: MONICA study 1988-89].
    Burnand B; Wietlisbach V; Riesen W; Noseda G; Barazzoni F; Rickenbach M; Gutzwiller F
    Schweiz Med Wochenschr Suppl; 1993; 48():29-37. PubMed ID: 8446869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyslipidemia as a risk factor at elderly age.
    Wenger NK
    Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):4-9. PubMed ID: 15133423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of risk factors, plasma lipids, lipoproteins and dyslipidemias in a small Mediterranean island: the Ustica Project.
    Barbagallo CM; Polizzi F; Severino M; Onorato F; Noto D; Cefalù AB; Rizzo M; Notarbartolo A; Averna MR
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):267-74. PubMed ID: 12616806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consequences of using different methods to assess cardiovascular risk in primary care.
    Fornasini M; Brotons C; Sellarès J; Martinez M; Galán ML; Sáenz I; da Pena JM
    Fam Pract; 2006 Feb; 23(1):28-33. PubMed ID: 16243952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diseases and nutrition: a primordial challenge in Public Health].
    Maillard C
    Servir; 2002; 50(5):241-3. PubMed ID: 12494528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular risk factors in a cohort of middle-aged women].
    Blümel JE; Castelo-Branco C; Roncagliolo ME; Binfa L; Sarrá S
    Rev Med Chil; 2003 Apr; 131(4):381-9. PubMed ID: 12870232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of familial hypercholesterolemia and of the dyslipidemias responsible for cardiovascular disease].
    Sampietro T; Licitra R
    G Ital Cardiol; 1999 Feb; 29(2):171-3. PubMed ID: 10088075
    [No Abstract]   [Full Text] [Related]  

  • 36. [Controversies and advances in the treatment of hyperlipidemias].
    Reza-Albarrán A; Aguilar-Salinas CA
    Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
    [No Abstract]   [Full Text] [Related]  

  • 37. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [National health survey--sobering facts].
    Küpper C
    Fortschr Med; 1996 Jul; 114(20-21):257-8. PubMed ID: 8926004
    [No Abstract]   [Full Text] [Related]  

  • 39. [Basic diagnosis of cardiovascular diseases--value of the combined use of a standardized anamnesis and blood pressure measurement].
    Bohm R; Günther KH; Petzschmann S; Läuter J
    Z Arztl Fortbild (Jena); 1987; 81(19):1003-5. PubMed ID: 3439212
    [No Abstract]   [Full Text] [Related]  

  • 40. Calculation of individual cardiovascular risk in a primary prevention setting shows a high number of patients with a high risk score.
    Neuss M; Roser M; Kelle S; Girke F; Winbeck G; Stawowy P; Fleck E
    Z Kardiol; 2004 May; 93(5):413-5. PubMed ID: 15160278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.